MTUS1 silencing promotes E-selectin production through p38 MAPK-dependent CREB ubiquitination in endothelial cells

Journal of Molecular and Cellular Cardiology

Volumn 101, Issue , 2016, Pages 1-10

  Wang, Yinfang ^a   Dai, Xiuqin ^a   Liu, Youbin ^a   Li, Jinping ^a   Liu, Zongjun ^a   Yin, Peihao ^a   Chen, Jingzhou ^b   Wang, Ying ^c   Wang, Nanping ^d   Zhang, Peng ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b FUWAI HOSPITAL   (China)

^c MAYO CLINIC   (United States)

^d DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

CREB; E selectin; Endothelial cells; MTUS1; p38 MAPK

Indexed keywords

APOLIPOPROTEIN E; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; SERINE; TRANSCRIPTION FACTOR RELA; CYTOKINE; MTUS1 PROTEIN, HUMAN; SELE PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

ADENOVIRIDAE; ANIMAL TISSUE; AORTA; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; GENE; GENE FUNCTION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFANT; LIPID DIET; LUCIFERASE ASSAY; MALE; MOUSE; MTUS1 GENE; NONHUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; QUANTITATIVE STUDY; SELE GENE; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; UBIQUITINATION; VIRUS EXPRESSION; ANIMAL; BIOSYNTHESIS; DEFICIENCY; GENE EXPRESSION; GENE VECTOR; GENETICS; KNOCKOUT MOUSE; METABOLISM; PHOSPHORYLATION;

ANIMALS; APOLIPOPROTEINS E; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; CYTOKINES; E-SELECTIN; ENDOTHELIAL CELLS; GENE EXPRESSION; GENE SILENCING; GENETIC VECTORS; HUMANS; MALE; MICE; MICE, KNOCKOUT; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS; UBIQUITINATION;

EID: 84995745292     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2016.10.012     Document Type: Article

References (39)

1. [1] Weber, C., Noels, H., Atherosclerosis: current pathogenesis and therapeutic options. Nat. Med. 17 (2011), 1410–1422.
2. [2] Weber, C., Zernecke, A., Libby, P., The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nat. Rev. Immunol. 8 (2008), 802–815.
3. [3] Distel, E., Barrett, T.J., Chung, K., Girgis, N.M., Parathath, S., Essau, C.C., et al. miR33 inhibition overcomes deleterious effects of diabetes mellitus on atherosclerosis plaque regression in mice. Circ. Res. 115 (2014), 759–769.
4. [4] Nigro, J., Osman, N., Dart, A.M., Little, P.J., Insulin resistance and atherosclerosis. Endocr. Rev. 27 (2006), 242–259.
5. [5] Mai, J., Nanayakkara, G., Lopez-Pastrana, J., Li, X., Li, Y.F., Wang, X., et al. Interleukin-17A promotes aortic endothelial cell activation via transcriptionally and post-translationally activating p38 MAPK pathway. J. Biol. Chem., 2016.
6. [6] Chiu, J.J., Chen, L.J., Lee, C.I., Lee, P.L., Lee, D.Y., Tsai, M.C., et al. Mechanisms of induction of endothelial cell E-selectin expression by smooth muscle cells and its inhibition by shear stress. Blood 110 (2007), 519–528.
7. [7] Kumar, P., Miller, A.I., Polverini, P.J., p38 MAPK mediates gamma-irradiation-induced endothelial cell apoptosis, and vascular endothelial growth factor protects endothelial cells through the phosphoinositide 3-kinase-Akt-Bcl-2 pathway. J. Biol. Chem. 279 (2004), 43352–43360.
8. [8] Nouet, S., Amzallag, N., Li, J.M., Louis, S., Seitz, I., Cui, T.X., et al. Trans-inactivation of receptor tyrosine kinases by novel angiotensin II AT2 receptor-interacting protein, ATIP. J. Biol. Chem. 279 (2004), 28989–28997.
9. [9] Rodrigues-Ferreira, S., Di Tommaso, A., Dimitrov, A., Cazaubon, S., Gruel, N., Colasson, H., et al. 8p22 MTUS1 gene product ATIP3 is a novel anti-mitotic protein underexpressed in invasive breast carcinoma of poor prognosis. PLoS One, 4, 2009, e7239.
10. [10] Louis, S.N., Chow, L., Rezmann, L., Krezel, M.A., Catt, K.J., Tikellis, C., et al. Expression and function of ATIP/MTUS1 in human prostate cancer cell lines. Prostate 70 (2010), 1563–1574.
11. [11] Zuern, C., Heimrich, J., Kaufmann, R., Richter, K.K., Settmacher, U., Wanner, C., et al. Down-regulation of MTUS1 in human colon tumors. Oncol. Rep. 23 (2010), 183–189.
12. [12] Rogler, A., Hoja, S., Giedl, J., Ekici, A.B., Wach, S., Taubert, H., et al. Loss of MTUS1/ATIP expression is associated with adverse outcome in advanced bladder carcinomas: data from a retrospective study. BMC Cancer, 14, 2014, 214.
13. [13] Shinoda, K., Luijten, I.H., Hasegawa, Y., Hong, H., Sonne, S.B., Kim, M., et al. Genetic and functional characterization of clonally derived adult human brown adipocytes. Nat. Med., 2015.
14. [14] Bundschu, K., Schuh, K., Cardiovascular ATIP (angiotensin receptor type 2 interacting protein) expression in mouse development. Dev. Dyn. 243 (2014), 699–711.
15. [15] Fujita, T., Mogi, M., Min, L.J., Iwanami, J., Tsukuda, K., Sakata, A., et al. Attenuation of cuff-induced neointimal formation by overexpression of angiotensin II type 2 receptor-interacting protein 1. Hypertension 53 (2009), 688–693.
16. [16] Min, L.J., Mogi, M., Iwanami, J., Jing, F., Tsukuda, K., Ohshima, K., et al. Angiotensin II type 2 receptor-interacting protein prevents vascular senescence. J. Am. Soc. Hypertens. 6 (2012), 179–184.
17. [17] Zuern, C., Krenacs, L., Starke, S., Heimrich, J., Palmetshofer, A., Holtmann, B., et al. Microtubule associated tumor suppressor 1 deficient mice develop spontaneous heart hypertrophy and SLE-like lymphoproliferative disease. Int. J. Oncol. 40 (2012), 1079–1088.
18. [18] Wang, Y., Zhang, Y., Dai, X., Liu, Z., Yin, P., Wang, N., et al. NR6A1 couples with cAMP response element binding protein and regulates vascular smooth muscle cell migration. Int. J. Biochem. Cell Biol. 69 (2015), 225–232.
19. [19] Wang, Y., Zhang, Y., Zhu, Y., Zhang, P., Lipolytic inhibitor G0/G1 switch gene 2 inhibits reactive oxygen species production and apoptosis in endothelial cells. Am. J. Phys. Cell Physiol. 308 (2015), C496–C504.
20. [20] Chen, J., Jiang, H., Yang, J., Chen, S.S., Xu, L., Down-regulation of CREB-binding protein expression blocks thrombin-mediated endothelial activation by inhibiting acetylation of NF-kappaB. Int. J. Cardiol. 154 (2012), 147–152.
21. [21] Di Benedetto, M., Bieche, I., Deshayes, F., Vacher, S., Nouet, S., Collura, V., et al. Structural organization and expression of human MTUS1, a candidate 8p22 tumor suppressor gene encoding a family of angiotensin II AT2 receptor-interacting proteins, ATIP. Gene 380 (2006), 127–136.
22. [22] Seibold, S., Rudroff, C., Weber, M., Galle, J., Wanner, C., Marx, M., Identification of a new tumor suppressor gene located at chromosome 8p21.3-22. FASEB J. 17 (2003), 1180–1182.
23. [23] Jing, F., Mogi, M., Min, L.J., Ohshima, K., Nakaoka, H., Tsukuda, K., et al. Effect of angiotensin II type 2 receptor-interacting protein on adipose tissue function via modulation of macrophage polarization. PLoS One, 8, 2013, e60067.
24. [24] Chen, T.C., Chien, S.J., Kuo, H.C., Huang, W.S., Sheen, J.M., Lin, T.H., et al. High glucose-treated macrophages augment E-selectin expression in endothelial cells. J. Biol. Chem. 286 (2011), 25564–25573.
25. [25] Shankar, R., de la Motte, C.A., Poptic, E.J., DiCorleto, P.E., Thrombin receptor-activating peptides differentially stimulate platelet-derived growth factor production, monocytic cell adhesion, and E-selectin expression in human umbilical vein endothelial cells. J. Biol. Chem. 269 (1994), 13936–13941.
26. [26] Choe, E.S., Wang, J.Q., CREB and Elk-1 phosphorylation by metabotropic glutamate receptors in striatal neurons (review). Int. J. Mol. Med. 9 (2002), 3–10.
27. [27] Schauer, I.E., Knaub, L.A., Lloyd, M., Watson, P.A., Gliwa, C., Lewis, K.E., et al. CREB downregulation in vascular disease: a common response to cardiovascular risk. Arterioscler. Thromb. Vasc. Biol. 30 (2010), 733–741.
28. [28] Elezaby, A., Sverdlov, A.L., Tu, V.H., Soni, K., Luptak, I., Qin, F., et al. Mitochondrial remodeling in mice with cardiomyocyte-specific lipid overload. J. Mol. Cell. Cardiol. 79 (2015), 275–283.
29. [29] Ding, B., Abe, J., Wei, H., Huang, Q., Walsh, R.A., Molina, C.A., et al. Functional role of phosphodiesterase 3 in cardiomyocyte apoptosis: implication in heart failure. Circulation 111 (2005), 2469–2476.
30. [30] Wen, A.Y., Sakamoto, K.M., Miller, L.S., The role of the transcription factor CREB in immune function. J. Immunol. 185 (2010), 6413–6419.
31. [31] Lee, Y.W., Eum, S.Y., Nath, A., Toborek, M., Estrogen-mediated protection against HIV tat protein-induced inflammatory pathways in human vascular endothelial cells. Cardiovasc. Res. 63 (2004), 139–148.
32. [32] Comerford, K.M., Leonard, M.O., Karhausen, J., Carey, R., Colgan, S.P., Taylor, C.T., Small ubiquitin-related modifier-1 modification mediates resolution of CREB-dependent responses to hypoxia. Proc. Natl. Acad. Sci. U. S. A. 100 (2003), 986–991.
33. [33] Garat, C.V., Fankell, D., Erickson, P.F., Reusch, J.E., Bauer, N.N., McMurtry, I.F., et al. Platelet-derived growth factor BB induces nuclear export and proteasomal degradation of CREB via phosphatidylinositol 3-kinase/Akt signaling in pulmonary artery smooth muscle cells. Mol. Cell. Biol. 26 (2006), 4934–4948.
34. [34] Gerritsen, M.E., Williams, A.J., Neish, A.S., Moore, S., Shi, Y., Collins, T., CREB-binding protein/p300 is transcriptional coactivators of p65. Proc. Natl. Acad. Sci. U. S. A. 94 (1997), 2927–2932.
35. [35] Edelstein, L.C., Pan, A., Collins, T., Chromatin modification and the endothelial-specific activation of the E-selectin gene. J. Biol. Chem. 280 (2005), 11192–11202.
36. [36] Ollivier, V., Parry, G.C., Cobb, R.R., de Prost, D., Mackman, N., Elevated cyclic AMP inhibits NF-kappaB-mediated transcription in human monocytic cells and endothelial cells. J. Biol. Chem. 271 (1996), 20828–20835.
37. [37] Parry, G.C., Mackman, N., Role of cyclic AMP response element-binding protein in cyclic AMP inhibition of NF-kappaB-mediated transcription. J. Immunol. 159 (1997), 5450–5456.
38. [38] Shenkar, R., Yum, H.K., Arcaroli, J., Kupfner, J., Abraham, E., Interactions between CBP, NF-kappaB, and CREB in the lungs after hemorrhage and endotoxemia. Am. J. Phys. Lung Cell. Mol. Phys. 281 (2001), L418–L426.
39. [39] Rius, J., Martinez-Gonzalez, J., Crespo, J., Badimon, L., Involvement of neuron-derived orphan receptor-1 (NOR-1) in LDL-induced mitogenic stimulus in vascular smooth muscle cells: role of CREB. Arterioscler. Thromb. Vasc. Biol. 24 (2004), 697–702.